Prescribing patterns and preferences for moderate-to-severe pediatric (<12 years of age) atopic dermatitis: A survey of Canadian practitioners
Michele L. Ramien, MDCM, MSc,
Vipul Jain, MD,
James Bergman, MD,
Danielle Marcoux, MD,
Irene Lara-Corrales, MDCM, MSc
Affiliations
Michele L. Ramien, MDCM, MSc
Department of Pediatrics, University of Calgary, Alberta Children’s Hospital, Calgary, Alberta, Canada; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Correspondence to: Michele L. Ramien, MDCM, MSc, Department of Pediatrics, University of Calgary, Alberta Children's Hospital, 28 Oki Dr NW, Calgary, Alberta, T3B 6A8, Canada
Vipul Jain, MD
Division of Clinical Immunology and Allergy, Department of Internal Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada; Probity Medical Research, Niagara Falls, Ontario, Canada; Allergy Research Canada Inc, Niagara Falls, Ontario, Canada
James Bergman, MD
Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada
Danielle Marcoux, MD
Division of Dermatology, Department of Pediatrics, Sainte-Justine University Hospital Center, University of Montreal, Montreal, Quebec, Canada
Irene Lara-Corrales, MDCM, MSc
The Hospital for Sick Children and Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada